Randomized Clinical Trial Design to Assess Abatacept in Resistant Nephrotic Syndrome

INTRODUCTION: Treatment-resistant nephrotic syndrome is a rare form of glomerular disease that occurs in children and adults. No Food and Drug Administration−approved treatments consistently achieve remission of proteinuria and preservation of kidney function. CD80 (B7-1) can be expressed on injured...

Descripción completa

Detalles Bibliográficos
Autores principales: Trachtman, Howard, Gipson, Debbie S., Somers, Michael, Spino, Cathie, Adler, Sharon, Holzman, Lawrence, Kopp, Jeffrey B., Sedor, John, Overfield, Sandra, Elegbe, Ayanbola, Maldonado, Michael, Greka, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762951/
https://www.ncbi.nlm.nih.gov/pubmed/29340321
http://dx.doi.org/10.1016/j.ekir.2017.08.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762951/
https://www.ncbi.nlm.nih.gov/pubmed/29340321
http://dx.doi.org/10.1016/j.ekir.2017.08.013

Ejemplares similares